Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice M Turner

Showing results (21-30 of 152) with videos related to

Pageof 16
Sort By:
Inflammation & Allergy Drug Targets|June 21, 2013
Vitamin D deficiency and acute lung injuryDhruv Parekh, David R Thickett, Alice M Turner
Medicina (Kaunas, Lithuania)|June 19, 2019
Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping ReviewSamuel P Trethewey, Neil Patel, Alice M Turner
Expert Opinion on Emerging Drugs|December 19, 2023
Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?Joshua De Soyza, Anita Pye, Alice M Turner
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 25, 2020
Exacerbations of Lung Disease in Alpha-1 Antitrypsin DeficiencyDaniel J Smith, Paul R Ellis, Alice M Turner
BMJ Open Respiratory Research|May 17, 2026
Within-individual variation of spirometry measurements in primary care: a retrospective cohort studyAlex Gough, Tom Marshall, Alice M Turner, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2021
Small Airways Disease, Biomarkers and COPD: Where are We?Priyamvada S Chukowry, Daniella A Spittle, Alice M Turner
Chest|June 22, 2013
Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in α1-antitrypsin deficiencyAnilkumar P Pillai, Alice M Turner, Robert A Stockley
Respiratory Research|April 3, 2016
Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPDJudith A Hampson, Robert A Stockley, Alice M Turner
Therapeutics and Clinical Risk Management|December 28, 2020
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current PerspectivesMark Quinn, Paul Ellis, Anita Pye, et al.
COPD|January 12, 2022
Prevalence, Pattern, Risks Factors and Consequences of Antibiotic Resistance in COPD: A Systematic ReviewDaniel Smith, Arran Gill, Lewis Hall, et al.
Pageof 16

Showing results (21-30 of 152) with videos related to

Sort By:
Pageof 16
Inflammation & Allergy Drug Targets|June 21, 2013
Vitamin D deficiency and acute lung injuryDhruv Parekh, David R Thickett, Alice M Turner
Medicina (Kaunas, Lithuania)|June 19, 2019
Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping ReviewSamuel P Trethewey, Neil Patel, Alice M Turner
Expert Opinion on Emerging Drugs|December 19, 2023
Are clinical trials into emerging drugs for the treatment of alpha-1 antitrypsin deficiency providing promising results?Joshua De Soyza, Anita Pye, Alice M Turner
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 25, 2020
Exacerbations of Lung Disease in Alpha-1 Antitrypsin DeficiencyDaniel J Smith, Paul R Ellis, Alice M Turner
BMJ Open Respiratory Research|May 17, 2026
Within-individual variation of spirometry measurements in primary care: a retrospective cohort studyAlex Gough, Tom Marshall, Alice M Turner, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2021
Small Airways Disease, Biomarkers and COPD: Where are We?Priyamvada S Chukowry, Daniella A Spittle, Alice M Turner
Chest|June 22, 2013
Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in α1-antitrypsin deficiencyAnilkumar P Pillai, Alice M Turner, Robert A Stockley
Respiratory Research|April 3, 2016
Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPDJudith A Hampson, Robert A Stockley, Alice M Turner
Therapeutics and Clinical Risk Management|December 28, 2020
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current PerspectivesMark Quinn, Paul Ellis, Anita Pye, et al.
COPD|January 12, 2022
Prevalence, Pattern, Risks Factors and Consequences of Antibiotic Resistance in COPD: A Systematic ReviewDaniel Smith, Arran Gill, Lewis Hall, et al.
Pageof 16